Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Danaher Corporation Acquires Abcam plc for $5.7 Billion
Danaher Corporation announced on August 28 that it has entered into a definitive agreement to acquire Abcam plc. According to data captured in the LevinPro HC database, this acquisition represents the 94th Laboratories, MRI and Dialysis transaction of 2023. Danaher will acquire all the currently outstanding shares of Abcam at a price of $24.00 per share in cash. In total, this acquisition is valued at approximately $5.7 billion, which factors in assumed debts and deducts acquired cash. Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its products include primary and secondary antibodies, proteins, peptides, lysates,... Read More »
Solis Mammography Acquires Carolina Breast Imaging Specialists
Solis Mammography, based in Addison, Texas, announced its acquisition of Carolina Breast Imaging Specialists for an undisclosed price. For more than 10 years, Carolina Breast Imaging Specialists has been providing patients care through a team of fellowship trained breast imaging specialists and state-of-the-art technology. It has three locations in North Carolina: Greenville, Goldboro and Wilson. Solis Mammography, a portfolio company of Madison Dearborn Partners since August 2018, is one of the largest independent providers of mammography and breast health services in the United States. It has more than 70 centers and has performed more than 5 million procedures. ... Read More »
PE-Backed Transnetyx Acquires Laragen
On August 23 Transnetyx, Inc., based in Cordova, Tennessee, announced its acquisition of Laragen, Inc. The financial terms were not disclosed. Laragen is a sequencing and genetic services company in Culver City, California. The company was founded in 1995. Transnetyx, a portfolio company of Thompson Street Capital Partners, is a fully-automated genotyping resource for thousands of researchers in universities, hospitals and bioscience companies around the world. It has genotyped more than 20 million samples in 24 or 72 hours with 99.97% accuracy. The addition of Laragen’s sanger sequencing and next-generation sequencing services to the Transnetyx solution suite will... Read More »
PE-Backed STARLIMS Acquires Labstep
STARLIMS, backed by Francisco Partners, announced on August 22 its acquisition of Labstep for an undisclosed price. According to data captured in the LevinPro HC database, this acquisition represents the 92nd Laboratories, MRI and Dialysis transaction of 2023 Labstep is a modern R&D cloud platform helping customers unlock the power of real-time data. Found in more than 900 universities and more than 65 companies worldwide, Labstep’s Electronic Laboratory Notebook (ELN) platform streamlines laboratory work, delivers real-time data capture and collaboration and enhances data integrity. STARLIMS provides enterprise informatics solutions and is committed to providing quality... Read More »
Fortis Life Sciences Acquires International Point of Care
Fortis Life Sciences, backed by Boston-based private equity firm Summit Partners, has acquired Toronto-based International Point of Care (IPOC). IPOC specializes in developing and manufacturing diagnostic components. IPOC serves many of the leading global diagnostic companies enabling the commercialization of new immunodiagnostic and molecular diagnostic technologies. Fortis Life Sciences partners with diagnostics and life sciences companies to custom-design, validate and manufacture proprietary solutions to solve their most difficult development problems. Fortis serves a global customer base and has offices worldwide including four R&D sites and three GMP and ISO 13485 compliant... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
